Your browser is no longer supported. Please, upgrade your browser.
AMGN [NASD]
Amgen Inc.
IndexDJIA S&P500 P/E22.10 EPS (ttm)9.84 Insider Own0.20% Shs Outstand573.00M Perf Week0.83%
Market Cap124.48B Forward P/E12.13 EPS next Y17.91 Insider Trans-0.41% Shs Float566.77M Perf Month-5.99%
Income5.75B PEG3.71 EPS next Q4.27 Inst Own77.50% Short Float1.98% Perf Quarter-9.72%
Sales25.48B P/S4.88 EPS this Y-4.40% Inst Trans-1.89% Short Ratio4.69 Perf Half Y-11.07%
Book/sh14.39 P/B15.10 EPS next Y9.12% ROA9.20% Target Price252.96 Perf Year-12.27%
Cash/sh14.11 P/C15.40 EPS next 5Y5.95% ROE60.60% 52W Range210.28 - 276.69 Perf YTD-5.46%
Dividend7.04 P/FCF24.87 EPS past 5Y6.30% ROI19.50% 52W High-21.44% Beta0.68
Dividend %3.24% Quick Ratio1.00 Sales past 5Y3.30% Gross Margin75.30% 52W Low3.37% ATR3.81
Employees24300 Current Ratio1.30 Sales Q/Q5.20% Oper. Margin29.10% RSI (14)37.70 Volatility1.76% 1.67%
OptionableYes Debt/Eq3.98 EPS Q/Q-73.60% Profit Margin22.50% Rel Volume1.07 Prev Close218.13
ShortableYes LT Debt/Eq3.45 EarningsAug 03 AMC Payout67.90% Avg Volume2.39M Price217.36
Recom2.50 SMA20-2.05% SMA50-6.54% SMA200-8.75% Volume2,695,607 Change-0.35%
Sep-07-21Downgrade Morgan Stanley Overweight → Equal-Weight $280 → $251
Dec-29-20Initiated Daiwa Securities Buy $300
Oct-28-20Initiated UBS Neutral $232
Oct-26-20Upgrade Raymond James Mkt Perform → Outperform $255
Oct-12-20Upgrade Truist Hold → Buy
Oct-09-20Downgrade Truist Buy → Hold $251
Oct-09-20Downgrade Bernstein Outperform → Mkt Perform
Oct-08-20Downgrade Raymond James Outperform → Mkt Perform
Apr-15-20Resumed Guggenheim Neutral
Mar-31-20Initiated Wolfe Research Peer Perform
Mar-30-20Upgrade Raymond James Mkt Perform → Outperform $255
Mar-05-20Upgrade BofA/Merrill Neutral → Buy $245 → $250
Feb-27-20Initiated Barclays Equal Weight $235
Jan-31-20Downgrade Robert W. Baird Neutral → Underperform $173 → $185
Jan-21-20Upgrade Evercore ISI In-line → Outperform
Dec-24-19Initiated Raymond James Mkt Perform
Dec-17-19Resumed Morgan Stanley Overweight $280
Nov-12-19Initiated SunTrust Buy $256
Nov-05-19Upgrade Cantor Fitzgerald Neutral → Overweight $230 → $255
Oct-17-19Resumed BofA/Merrill Neutral $215
Sep-16-21 08:17AM  
08:08AM  
04:30AM  
Sep-14-21 04:00PM  
Sep-13-21 04:15PM  
04:00PM  
09:00AM  
Sep-11-21 07:05AM  
Sep-09-21 07:01PM  
05:00PM  
07:19AM  
06:29AM  
Sep-08-21 04:00PM  
08:31AM  
Sep-07-21 04:22PM  
04:00PM  
02:40PM  
12:18PM  
11:29AM  
10:23AM  
08:28AM  
Sep-05-21 07:15AM  
Sep-03-21 04:00PM  
Sep-02-21 05:50PM  
11:31AM  
08:00AM  
Aug-30-21 10:16AM  
Aug-27-21 12:11PM  
04:30AM  
Aug-19-21 03:56PM  
Aug-12-21 03:00PM  
Aug-11-21 07:55AM  
Aug-09-21 04:28PM  
Aug-06-21 01:43PM  
Aug-05-21 04:25PM  
01:59PM  
05:48AM  
Aug-04-21 04:16PM  
03:30PM  
02:44PM  
12:15PM  
10:30AM  
09:52AM  
04:12AM  
Aug-03-21 10:31PM  
06:09PM  
05:15PM  
04:34PM  
04:31PM  
04:20PM  
04:07PM  
04:01PM  
12:40PM  
Aug-02-21 05:21PM  
09:36AM  
Aug-01-21 10:32AM  
Jul-30-21 04:00PM  
12:31PM  
11:21AM  
Jul-29-21 07:10PM  
05:35PM  
04:00PM  
Jul-28-21 01:51PM  
08:50AM  
06:55AM  
Jul-27-21 04:19PM  
03:02PM  
Jul-22-21 11:10AM  
Jul-21-21 08:12PM  
Jul-20-21 01:48AM  
Jul-15-21 12:19PM  
Jul-14-21 03:21PM  
08:00AM  
Jul-09-21 08:10AM  
06:16AM  
Jul-08-21 12:15PM  
11:53AM  
07:01AM  
03:04AM  
02:00AM  
Jul-07-21 12:07PM  
Jul-05-21 07:51AM  
Jun-30-21 06:43AM  
Jun-29-21 03:01PM  
Jun-24-21 12:38PM  
Jun-23-21 04:00AM  
Jun-21-21 11:51AM  
Jun-18-21 05:00AM  
Jun-17-21 10:54AM  
Jun-15-21 08:00AM  
Jun-14-21 01:45AM  
Jun-08-21 10:02AM  
Jun-07-21 09:33AM  
Jun-04-21 05:00PM  
04:00PM  
10:39AM  
09:00AM  
Jun-02-21 06:13AM  
01:44AM  
Jun-01-21 07:00PM  
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces the chance of infection due a low white blood cell count in patients cancer; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behcet's disease; Aranesp to treat a lower-than-normal number of red blood cells and anemia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; and Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization. It also markets Nplate, Vectibix, MVASI, Parsabiv, EPOGEN, KANJINTI, BLINCYTO, Aimovig, EVENITY, AMGEVITATM, Sensipar/Mimpara, NEUPOGEN, IMLYGIC, Corlanor, and AVSOLA. Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaboration agreements with Novartis Pharma AG; UCB; Bayer HealthCare LLC; BeiGene, Ltd.; Eli Lilly and Company; and Datos Health. It also has an agreement with Kyowa Kirin Co., Ltd. to jointly develop and commercialize KHK4083, a Phase 3-ready anti-OX40 fully human monoclonal antibody for the treatment of atopic dermatitis and other autoimmune diseases. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SUGAR RONALD DDirectorMay 12Option Exercise71.641,00071,64016,927May 12 08:11 PM
SUGAR RONALD DDirectorMay 12Sale250.591,000250,59015,927May 12 08:11 PM
Grygiel Nancy A.SVP & CCOMay 11Option Exercise162.602,500406,50014,961May 12 08:10 PM
Grygiel Nancy A.SVP & CCOMay 11Sale252.512,500631,27212,461May 12 08:10 PM
Williams R SandersDirectorMay 07Sale251.7825062,9454,409May 10 06:38 PM
SUGAR RONALD DDirectorApr 14Option Exercise71.641,00071,64016,927Apr 15 06:27 PM
SUGAR RONALD DDirectorApr 14Sale249.981,000249,98015,927Apr 15 06:27 PM
SUGAR RONALD DDirectorMar 10Option Exercise71.641,00071,64016,805Mar 10 06:07 PM
SUGAR RONALD DDirectorMar 10Sale231.531,000231,53015,805Mar 10 06:07 PM
Bradway Robert AChairman, CEO and PresidentFeb 18Option Exercise54.6973,5004,019,715618,380Feb 22 07:27 PM
REESE DAVID MEVP, Research and DevelopmentFeb 16Option Exercise54.692,300125,78742,059Feb 16 08:59 PM
SUGAR RONALD DDirectorFeb 10Option Exercise71.641,00071,64016,805Feb 10 07:40 PM
SUGAR RONALD DDirectorFeb 10Sale238.401,000238,40015,805Feb 10 07:40 PM
Williams R SandersDirectorFeb 08Sale237.9925059,4984,659Feb 08 08:36 PM
Graham Jonathan PEVP, Gen. Counsel & Secy.Feb 04Sale236.5111,1102,627,62539,945Feb 05 08:06 PM
SUGAR RONALD DDirectorJan 13Option Exercise71.641,00071,64016,805Jan 14 06:25 PM
SUGAR RONALD DDirectorJan 13Sale235.991,000235,99015,805Jan 14 06:25 PM
Williams R SandersDirectorNov 09Sale242.4025060,6004,909Nov 10 06:32 PM